From: Dr. James Coleman [info@cancerresearchamerica.org]
Sent: Saturday, September 14, 2002 2:25 AM
To: fdadockets@oc.fda.gov
Subject: Docket No. 01N-0067 - Against FDA Rule
To Whom It May Concern:
I support Consumers for Dental Choice in wanting mercury amalgams classified as Class III where the manufacturers would be required to carry the burden of proving safety of their products.
I further request that the FDA use the most recent and most relevant research from peer reviewed scientific publications in its decision-making process.
I further request a public hearing and REBUTTAL and REPLY after new 60-day Comment period, and finally, I request a NEW Advisory Panel regarding mercury dental fillings.
I believe that FDA's existing rule would undermine the efforts by states that have developed strong laws with disclosure language on the risks of mercury fillings.
Sincerely,
James Coleman, Ph.D.
President/CEO
Cancer Research Center of America, Inc.
8622 Blackpool Drive
Louisville, KY 40222-5667
Tel (502) 339-1282
Fax (502) 339-1134
Web site: www.CancerResearchAmerica.org